Search Results - "Gordon, W. Perry"

Refine Results
  1. 1
  2. 2
  3. 3

    Interstrain differences of in vitro metabolic stability and impact on early drug discovery by Richmond, Wendy, Wogan, Megan, Isbell, John, Gordon, W Perry

    Published in Journal of pharmaceutical sciences (01-11-2010)
    “…With the extensive use of different strains of mice and rats in in vivo efficacy models, lack of relevant metabolic clearance data among strains has been a…”
    Get more information
    Journal Article
  4. 4
  5. 5

    TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts by Croucher, Jamie L., Iyer, Radhika, Li, Nanxin, Molteni, Valentina, Loren, Jon, Gordon, W. Perry, Tuntland, Tove, Liu, Bo, Brodeur, Garrett M.

    Published in Cancer chemotherapy and pharmacology (01-01-2015)
    “…Purpose Neuroblastoma (NB) is one of the most common and deadly pediatric solid tumors. NB is characterized by clinical heterogeneity, from spontaneous…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Investigations of mechanisms of reactive metabolite formation from (R)-(+)-pulegone by Nelson, S D, McClanahan, R H, Thomassen, D, Gordon, W P, Knebel, N

    Published in Xenobiotica (1992)
    “…1. (R)-(+)-Pulegone is a monoterpene that is oxidized by cytochromes P-450 to reactive metabolites that initiate events in the pathogenesis of hepatotoxicity…”
    Get more information
    Journal Article
  8. 8

    The genotoxicity of 2-bromoacrolein and 2,3-dibromopropanal by Gordon, W P, Søderlund, E J, Holme, J A, Nelson, S D, Iyer, L, Rivedal, E, Dybing, E

    Published in Carcinogenesis (New York) (01-05-1985)
    “…2-Bromoacrolein (2-BA) and 2,3-dibromopropanal (2,3-DBPA), an identified and a postulated reactive metabolite of tris(2,3-dibromopropyl)phosphate (Tris-BP),…”
    Get more information
    Journal Article
  9. 9

    Studies on the mechanism of acetamide hepatocarcinogenicity by Dybing, E, Søderlund, E J, Gordon, W P, Holme, J A, Christensen, T, Becher, G, Rivedal, E, Thorgeirsson, S S

    Published in Pharmacology & toxicology (01-01-1987)
    “…The hepatocarcinogen acetamide, in single doses of 100 and 400 mg/kg b.wt., was shown to act as an initiator in a dose-dependent fashion in rat liver using the…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Disposition of 8-methyl-8-azabicyclo[3,2,1]octan-3-yl 3,5-dichlorobenzoate, a potent 5-hydroxytryptamine antagonist, and two metabolites in dogs and monkeys by Cheng, H, Larsen, D L, Ragner, J A, Sproles, G D, Gordon, W P

    Published in Journal of pharmaceutical sciences (01-04-1992)
    “…The disposition of 8-methyl-8-azabicyclo[3,2,1]octan-3-yl 3,5-dichlorobenzoate (MDL 72,222; 1), a potent 5-hydroxytryptamine antagonist, and its N-demethylated…”
    Get more information
    Journal Article
  12. 12

    Identification of urinary metabolites of 8-methyl-8-azabicyclo-[3,2,1] octan-3-yl 3,5-dichlorobenzoate (MDL 72,222) in the dog and monkey by Gordon, W P, Cheng, H, Larsen, D L, Ragner, J A, Landmesser, N G

    Published in Drug metabolism and disposition (01-07-1992)
    “…The metabolism of 8-methyl-8-azabicyclo- 3,2,1]octan-3-yl 3,5-dichlorobenzoate (MDL 72,222) was studied in the dog and monkey. Four urinary metabolites were…”
    Get more information
    Journal Article
  13. 13

    Metabolism in vitro of tris(2,3-dibromopropyl)-phosphate: oxidative debromination and bis(2,3-dibromopropyl)phosphate formation as correlates of mutagenicity and covalent protein binding by Søderlund, E J, Gordon, W P, Nelson, S D, Omichinski, J G, Dybing, E

    Published in Biochemical pharmacology (15-12-1984)
    “…Tris(2,3-dibromopropyl)phosphate (Tris-BP) was found to be metabolized by liver microsomes obtained from untreated and phenobarbital-pretreated rats…”
    Get more information
    Journal Article
  14. 14

    Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein by Nelson, S D, Omichinski, J G, Iyer, L, Gordon, W P, Soderlund, E J, Dybing, E

    “…The potent mutagen 2- bromoacrolein is formed from the carcinogenic flame retardant tris(2,3-dibromopropyl)phosphate (Tris-BP) on incubation with hepatic…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Metabolism of 2-(2-thienyl)allylamine hydrochloride in the rat: identification of a novel metabolite by Gordon, W P, McCarthy, J R, Chang, S Y

    “…A novel metabolite, 2-(2-thienyl)propionic acid, is formed in vivo from 2-(2-thienyl)allylamine hydrochloride. Mass spectral analysis suggested…”
    Get more information
    Journal Article
  17. 17

    Mammalian Drug Metabolism by Nelson, Sidney D, Gordon, W. Perry

    “…Drugs and other chemicals that do not occur in mammalian systems are metabolized by a wide variety of enzymes. Reactions catalyzed by these enzymes have been…”
    Get full text
    Journal Article
  18. 18

    Carcinogenicity of deuterium-labeled 1,2-dimethylhydrazine in mice by TURUSOV, V. S, LANKO, N. S, PARFENOV, Y. D, GORDON, W. P, NELSON, S. D, HILLERY, P. S, KEEFER, L. K

    Published in Cancer research (Chicago, Ill.) (15-04-1988)
    “…To study the effect of deuterium substitution on the carcinogenicity of 1,2-dimethylhydrazine (DMH) in mice, two comparisons were made between DMH and its…”
    Get full text
    Journal Article
  19. 19

    Procarbazine spermatogenesis toxicity: deuterium isotope effects point to regioselective metabolism in mice by Yost, G S, Horstman, M G, el Walily, A F, Gordon, W P, Nelson, S D

    Published in Toxicology and applied pharmacology (15-09-1985)
    “…Procarbazine was shown to decrease spermatogenesis in male mice in a dose-dependent manner. Significant decreases (44% of controls) in spermatogenesis were…”
    Get more information
    Journal Article
  20. 20